leon nanodrugs

the future of nanoparticle manufacturing

leon nanodrugs is a biotech company in Planegg, Germany, founded in 2011. It has raised $20.5M across 2 rounds, most recently a Series D in August 2024.

Headquarters
Planegg, Bavaria
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$20.5M
Last Round
Series DAug 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

leon nanodrugs develops and commercializes equipment that encapsulates active pharmaceutical ingredients, including genetic payloads, into nanoparticles for advanced drug delivery. Its systems support process development and GMP production for pharmaceutical manufacturers, biotechnology organizations, and contract development and manufacturing organizations. The equipment is designed to accelerate time to market for new therapies.

Summary

It lists 11–50 employees. It has raised $20.5M in total across 2 rounds, most recently a Series D round in Aug 2024. Investors include LBBW Venture Capital and Signet Healthcare Partners.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series DSeries DAug 2024

Sign up to see all 2 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

leon nanodrugs on Indexed.vc
<a href="https://indexed.vc/companies/leon-nanodrugs"><img src="https://indexed.vc/api/badge/company/leon-nanodrugs" alt="leon nanodrugs on Indexed.vc" width="260" height="76" /></a>